triamcinolone has been researched along with moxifloxacin in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Banta, JT; Flynn, HW; Schimel, AM; Stringham, JD | 1 |
Dhaliwal, DK; Kowalski, RP; Mammen, A; Romanowski, EG; Shanks, RMQ | 1 |
Bond, WI; Brown, JA; Hahn, JM; Kishore, K; Satar, JM | 1 |
Chalam, KV; Ng, C | 1 |
Jeeva, IK; Masud, S; Siddiqui, MAR | 1 |
6 other study(ies) available for triamcinolone and moxifloxacin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Dropless Cataract Surgery: What Are the Potential Downsides?
Topics: Anti-Infective Agents, Local; Antibiotic Prophylaxis; Drug Compounding; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Glucocorticoids; Humans; Lens Implantation, Intraocular; Moxifloxacin; Ocular Hypertension; Ophthalmic Solutions; Phacoemulsification; Risk Factors; Triamcinolone; Vancomycin | 2016 |
Postsurgical Cataract Prophylaxis With Intravitreal "Triamcinolone-Moxifloxacin" May Not Be Optimal For Preventing Endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Intravitreal Injections; Male; Moxifloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Triamcinolone | 2018 |
Acute-onset postoperative endophthalmitis after cataract surgery and transzonular intravitreal triamcinolone-moxifloxacin.
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Combinations; Endophthalmitis; Eye Infections, Bacterial; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Male; Moxifloxacin; Phacoemulsification; Retrospective Studies; Surgical Wound Infection; Triamcinolone | 2018 |
Endophthalmitis after dropless (Tri-Moxi injection) cataract surgery.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Cataract Extraction; Drug Combinations; Drug Implants; Drug Resistance, Bacterial; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Humans; Intravitreal Injections; Male; Moxifloxacin; Staphylococcal Infections; Staphylococcus epidermidis; Tobramycin, Dexamethasone Drug Combination; Triamcinolone; Vancomycin; Vitrectomy | 2020 |
Efficacy and safety of intravitreal injection of triamcinolone-moxifloxacin after cataract surgery in a low to middle income country - a one-year audit.
Topics: Adult; Aged; Cataract; Cataract Extraction; Developing Countries; Endophthalmitis; Eye Diseases; Female; Glucocorticoids; Humans; Inflammation; Intravitreal Injections; Male; Middle Aged; Moxifloxacin; Postoperative Complications; Retrospective Studies; Triamcinolone | 2023 |